Académique Documents
Professionnel Documents
Culture Documents
Pregnancy
Ario danianto
IDENTITY
• Name : Ms. C C
• Age : 30 y.o
• Address : Peterongan, Jombang
• RM : 12.30.20.31
• LMP : 09 Sept 2013
• Parity : GII P0010
2
07-01-2014
Sent by OBGYN (Jombang) with GII P00010
19-20 Week S/L + Cystoma ovarii
(multilokuler) + SOT
2014
Outpatient clinic I Tgl. 07-01-2014
Obstetrik Statuse Diagnose GII P0010
VT : v/v : fluksus(-), fluor(+) 21/22 Week SLIU + BOH
P : Closed smooth +
CU : AF ~ 20 week SOT (D) + kista
AP (D) : mass (+) Ø 5 cm, solid, ovarium (S)
mobile, pain (-) Planning :
AP (S) : mass (+) cyst, mobile, pain -USG FM
(-) - Ca 125, Ca 19-9,
CD : normal
USG FM (07-01-2014) :
Breech /S/L
BPD : 5,48 ~ 22/23 week
FL : 373 ~ 21/22 week
HC : 20,19 ~ 22/23 week
AC : 17,79 ~ 22/23 week
Plac. Corpus anterior/gr I/Amnion fluid enough
Hiperechoic mass in corpus anterior uterine Ø 6,18x7,88
cm
Hipoechoic mass in lateral uterine bersepta Ø 6,77 cm x 7,07
cm. Papile (+)
Inscribe : gravida + mioma + kista ovarium
VT :
P : close, smooth
CU : ~ pregnant 24 week
Diagnose :
Plan : - konservatif
- Tumor board
• Incidence of adnexal masses in pregnancy ranges
from 1 in 81 to 1 in 8000 pregnancies
Hoover. Evaluation and management of adnexal mass in pregnancy. Am J Obstet Gynecol 2011.
• Adnexal masses in pregnancy are diagnosed
incidentally during a screening ultrasound in the
first trimester
Hoover. Evaluation and management of adnexal mass in pregnancy. Am J Obstet Gynecol 2011.
Sonographic characteristics of an
adnexal mass
Hosam. Management of ovarian masses in pregnancy. Treds in urology sexual health jan 2009
Etiology of ovarian tumors during
pregnancy
Leiserowitz. Managing ovarian masses during pregnancy. Obstet Gynecol Surgery 2006.
Tumor markers
• CA-125 levels are elevated in pregnancy, particularly
in the first trimester
• CA-125 also elevated with other benign disease
processes such as menses, uterine fibroids,and
endometriomas
• AFP, βHCG, and LDH altered by pregnancy
• The primary value of tumor markers in pregnancy is
in the ability to follow their levels as an indicator of
tumor control
Hoover. Evaluation and management of adnexal mass in pregnancy. Am J Obstet Gynecol 2011.
Spencer, Robarts. Review Management of adnexal masses in pregnancy. RCOG;8:14-19, 2006.
Management
• Still controversial
• Some investigators recommending observation, and
others, surgical management
• The main consideration in choosing intervention
versus expectant management centers on the risks
to the mother and fetus
• Most ovarian masses in pregnancy will
spontaneously resolve, and aggressive surgical
management is not required
Hoover. Evaluation and management of adnexal mass in pregnancy. Am J Obstet Gynecol 2011.
Surgical Management
• Following indications:
• 2) symptomatic complaints
• 3) an increased risk of
torsion/rupture/obstruction of labor
Leiserowitz. Managing ovarian masses during pregnancy. Obstet Gynecol Surgery 2006.
Surgical Management
• Surgical management suggests a trend toward
improved fetal and maternal outcomes by utilizing
midgestation (17-27 weeks)
Hoover. Evaluation and management of adnexal mass in pregnancy. Am J Obstet Gynecol 2011.
Observational management
Hoover. Evaluation and management of adnexal mass in pregnancy. Am J Obstet Gynecol 2011.
Spencer, Robarts. Review Management of adnexal masses in pregnancy. RCOG;8:14-19, 2006.